Vaccine News and Research

Latest Vaccine News and Research

Aloe vera powder nose spray vaccine shows potential for bird flu treatment

Researchers at Texas A&M University are participating in developing a medicine that is worth sneezing about: a treatment for influenza that forms a jelly when sprayed into the nose.

26 Sep 2007

NanoBio expands drug development team

NanoBio Corporation has announced the addition of four new scientists to its drug development team.

26 Sep 2007

Discovery of structure in malaria with potential for a vaccine target

Researchers at the Swedish medical university Karolinska Institutet (KI) and the Swedish Institute for Infectious Disease Control (SMI) have identified the biochemical mechanism behind the adhesive protein that give rise to particularly serious malaria in children.

25 Sep 2007

Space flight makes bacteria more infectious

Space flight has been shown to have a profound impact on human physiology as the body adapts to zero gravity environments.

25 Sep 2007

Need for better flu vaccines for seniors

Each year, seasonal flu kills approximately 36,000 people in the United States, most over age 70.

25 Sep 2007

New topical lotion safely treats nail fungus without side effects

A new topical lotion that penetrates the skin deeply enough to target and eliminate serious skin infections, but without being systemically absorbed, has shown a high degree of safety and tolerability in patients with onychomycosis, or toenail fungus, a new study has shown.

25 Sep 2007

China in denial over pig disease

Agriculture officials in China have denied the country is the source of blue ear disease outbreaks among pigs in Vietnam and Myanmar.

24 Sep 2007

Trials of a new HIV vaccine come to an abrupt halt

Trials of a new HIV vaccine have come to an abrupt halt after it did not prevent volunteers from becoming infected.

24 Sep 2007

Process of care failures in invasive cervical cancer: Systematic review and meta-analysis

The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened.

24 Sep 2007

AIDS Vaccine Advocacy Coalition voices disappointment in trial results for MRK-Ad5 AIDS vaccine candidate

The AIDS Vaccine Advocacy Coalition (AVAC) released the following statement from Executive Director Mitchell Warren about the announcement that vaccinations have been discontinued in the STEP Study, a test-of-concept trial of the MRK-Ad5 AIDS vaccine candidate developed by the Merck Research Laboratories.

23 Sep 2007

Brugia malayi's secrets revealed

An international team of researchers has revealed the genetic secrets of one of the world's most debilitating human parasites, Brugia malayi (B. malayi), which the World Health Organization estimates has seriously incapacitated and disfigured more than 40 million people around the globe.

21 Sep 2007

Scientists solve genetic code of parasitic worm that causes elephantiasis

More than 150 million people worldwide are infected with filarial parasites -- long, thread-like worms that can live for years inside the human body and cause severe, debilitating diseases such as elephantiasis.

21 Sep 2007

Flu virus migrates globally all year round

The influenza A virus does not lie dormant during summer but migrates globally and mixes with other viral strains before returning to the Northern Hemisphere as a genetically different virus, according to biologists who say the finding settles a key debate on what the virus does during the summer off season when it is not infecting people.

21 Sep 2007

FDA expands use of influenza vaccine FluMist

The U.S. Food and Drug Administration has approved expanding the population for use of the nasal influenza vaccine FluMist to include children between the ages of 2 and 5.

20 Sep 2007

Cases of invasive pneumococcal disease in children reduced

The number of cases of invasive pneumococcal disease (IPD) in children has fallen since the introduction of a new vaccine a year ago. Enhanced surveillance by the UK's Health Protection Agency has shown that cases of IPD caused by the seven major types of the pneumococcus bacteria which the new pneumococcal conjugate vaccine (PCV) protects against have gone down by almost 50%.

20 Sep 2007

Modelling data reveals cost effectiveness of HPV vaccine

New modelling research presented at the Health Protection Agency's annual conference will show that up to 70% of cases of cervical cancer and 95% of cases of genital warts in men and women could be prevented by the introduction of human papilloma virus (HPV) vaccination into the UK 's national immunisation programme. This is in addition to the cancer cases already prevented by the NHS cervical screening programme.

20 Sep 2007